These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 1649745)

  • 21. Affinity of MC 903 for 1,25-dihydroxyvitamin D receptor and its effects on the synthesis of osteocalcin in human osteosarcoma cells.
    Valaja T; Mahonen A; Pirskanen A; Mäenpää PH
    Biochem Pharmacol; 1990 Oct; 40(8):1827-32. PubMed ID: 2173591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of 1,25-dihydroxyvitamin D3-analogs on osteoblast-like cells and on in vitro bone resorption.
    van den Bemd GJ; Pols HA; Birkenhäger JC; Kleinekoort WM; van Leeuwen JP
    J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):337-46. PubMed ID: 8541230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation by retinoic acid of 1,25-dihydroxyvitamin D3 effects on alkaline phosphatase activity and parathyroid hormone responsiveness in an osteoblast-like osteosarcoma cell line.
    Grigoriadis AE; Petkovich PM; Rosenthal EE; Heersche JN
    Endocrinology; 1986 Aug; 119(2):932-9. PubMed ID: 3015560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
    Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC
    Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological and biochemical evidence for the regulation of osteocalcin secretion by potassium channels in human osteoblast-like MG-63 cells.
    Moreau R; Aubin R; Lapointe JY; Lajeunesse D
    J Bone Miner Res; 1997 Dec; 12(12):1984-92. PubMed ID: 9421231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Actions of calcipotriol (MC 903), a novel vitamin D3 analog, on human bone-derived cells: comparison with 1,25-dihydroxyvitamin D3.
    Evans DB; Thavarajah M; Binderup L; Kanis JA
    J Bone Miner Res; 1991 Dec; 6(12):1307-15. PubMed ID: 1792941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
    Miyahara T; Simoura T; Osahune N; Uchida Y; Sakuma T; Nemoto N; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Chiba H; Iba K; Sawada N
    Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrocortisone and deflazacort induce different effects on vitamin D receptor level increase produced by 1,25-dihydroxyvitamin D3 in rat osteoblast-like UMR-106 cells.
    Guerrero R; de la Piedra C; Teixeiro E; Bragado R; Traba ML
    J Rheumatol; 2004 Jan; 31(1):167-72. PubMed ID: 14705237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming growth factor beta-induced dissociation between vitamin D receptor level and 1,25-dihydroxyvitamin D3 action in osteoblast-like cells.
    Staal A; Birkenhäger JC; Pols HA; Buurman CJ; Vink-van Wijngaarden T; Kleinekoort WM; van den Bemd GJ; van Leeuwen JP
    Bone Miner; 1994 Jul; 26(1):27-42. PubMed ID: 7950503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a highly potent fluoro analog of 1,25-dihydroxyvitamin D3 on human bone-derived cells.
    Kiriyama T; Okamoto S; Ejima E; Kurihara N; Hakeda Y; Ito N; Izumi M; Kumegawa M; Nagataki S
    Endocrinology; 1991 Jan; 128(1):81-6. PubMed ID: 1846118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posttranscriptional regulation of osteocalcin mRNA in clonal osteoblast cells by 1,25-dihydroxyvitamin D3.
    Mosavin R; Mellon WS
    Arch Biochem Biophys; 1996 Aug; 332(1):142-52. PubMed ID: 8806719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
    Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Affinity of 22-oxa-1,25(OH)2D3 for 1,25-dihydroxyvitamin D receptor and its effects on the synthesis of osteocalcin in human osteosarcoma cells.
    Valaja T; Mahonen A; Pirskanen A; Mäenpää PH
    Biochem Biophys Res Commun; 1990 Jun; 169(2):629-35. PubMed ID: 2162670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells.
    Spiess YH; Price PA; Deftos JL; Manolagas SC
    Endocrinology; 1986 Apr; 118(4):1340-6. PubMed ID: 3485045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells.
    Inaba M; Terada M; Koyama H; Yoshida O; Ishimura E; Kawagishi T; Okuno Y; Nishizawa Y; Otani S; Morii H
    J Bone Miner Res; 1995 Jul; 10(7):1050-6. PubMed ID: 7484280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An AP-1 site in the nerve growth factor promoter is essential for 1, 25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts.
    Veenstra TD; Fahnestock M; Kumar R
    Biochemistry; 1998 Apr; 37(17):5988-94. PubMed ID: 9558335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the mechanisms for the selective action of vitamin D analogs.
    Dusso AS; Negrea L; Gunawardhana S; Lopez-Hilker S; Finch J; Mori T; Nishii Y; Slatopolsky E; Brown AJ
    Endocrinology; 1991 Apr; 128(4):1687-92. PubMed ID: 2004595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3.
    Norman AW; Bouillon R; Farach-Carson MC; Bishop JE; Zhou LX; Nemere I; Zhao J; Muralidharan KR; Okamura WH
    J Biol Chem; 1993 Sep; 268(27):20022-30. PubMed ID: 8397195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.